Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-26

FDA Approved: FONDAPARINUX SODIUM — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved a generic version of fondaparinux sodium (Eugia US LLC) through an Original ANDA, enabling use of this anticoagulant for preventing and treating ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fondaparinux sodium (Fondaparinux sodium)

Snippet

ORIG AP for FONDAPARINUX SODIUM (FONDAPARINUX SODIUM)